Literature DB >> 12076714

Expression of cyclooxygenase 2 and cytosolic phospholipase A(2) in the liver tissue of patients with chronic hepatitis and liver cirrhosis.

Jidong Cheng1, Hiroyasu Imanishi, Hiroko Iijima, Soji Shimomura, Tetsuya Yamamoto, Yoshiki Amuro, Akira Kubota, Toshikazu Hada.   

Abstract

Cyclooxgenase (COX) and phospholipase A(2) (PLA(2)) are crucial rate-limiting enzymes involved in the conversion of arachidonic acid to prostaglandin H(2), the precursor of various compounds including prostaglandins (PGs), prostacyclin, and thromboxanes in the process of PGs' synthesis. Recent studies have shown increased levels of COX(2) in adjacent cirrhotic tissue of hepatocellular carcinoma. The relationship between the expression of COX(2) or cytosolicPLA(2) (cPLA(2)) and liver fibrosis has not been described previously. We used 45 formalin-fixed, paraffin-embedded liver tissue samples obtained by needle biopsies from patients with chronic hepatitis, consisting of 7 cases of F(0), 10 cases of F(1), 10 cases of F(2), 9 cases of F(3) and 9 cases of liver cirrhosis (LC) according to the New Inuyama Classification of the staging of liver fibrosis. The expression of COX(2) and cPLA(2) was investigated by immunohistochemistry, western blotting and image analysis. The positive signals for COX(2) and cPLA(2) were observed in the cytoplasm of hepatocytes. The signal intensity of COX(2) increased significantly with the progression of liver fibrosis (P<0.001) and no significant difference was observed in the relative amount of cPLA(2) from group F(0) to group LC. According to the New Inuyama Classification of hepatitis activity grading, 45 samples were classified as group A(1) (23 cases), group A(2) (19 cases) and group A(3) (3 cases). No significant differences were found in the relative amount of COX(2) and cPLA(2) between group A(1) and group A(2-3). Significant correlation was observed between the relative amount of COX(2) and hyaluronan (P<0.01). Our findings suggested that COX(2) may be involved in liver fibrogenesis.

Entities:  

Year:  2002        PMID: 12076714     DOI: 10.1016/s1386-6346(01)00177-2

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  15 in total

1.  Celecoxib inhibits proliferation and induces apoptosis via cyclooxygenase-2 pathway in human pancreatic carcinoma cells.

Authors:  Gaosong Wu; Jilin Yi; Fang Di; Shengquan Zou; Xingrui Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

2.  Overexpression of cyclooxygenase-2 in noncancerous liver tissue increases the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis.

Authors:  Yi-Fu He; Juan Jin; Wei Wei; Yan Chang; Bing Hu; Chu-Shu Ji; Wei-Dong Jia; Xiao-Qiu Wang; Ke Chen; Jian Chen
Journal:  Can J Gastroenterol       Date:  2010-07       Impact factor: 3.522

3.  Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC).

Authors:  Yu Yang; Jiang Zhu; Hongfeng Gou; Dan Cao; Ming Jiang; Mei Hou
Journal:  Med Oncol       Date:  2010-04-17       Impact factor: 3.064

4.  Prostaglandin E2 induces contraction of liver myofibroblasts by activating EP3 and FP prostanoid receptors.

Authors:  S Ayabe; T Murata; T Maruyama; M Hori; H Ozaki
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

5.  HBx targeting to mitochondria and ROS generation are necessary but insufficient for HBV-induced cyclooxygenase-2 expression.

Authors:  Wonchung Lim; Soon-Hwan Kwon; Hyeseon Cho; Sujeong Kim; Seungmin Lee; Wang-Shick Ryu; Hyeseong Cho
Journal:  J Mol Med (Berl)       Date:  2009-11-26       Impact factor: 4.599

6.  Transgenic expression of cyclooxygenase-2 in hepatocytes accelerates endotoxin-induced acute liver failure.

Authors:  Chang Han; Guiying Li; Kyu Lim; Marie C DeFrances; Chandrashekhar R Gandhi; Tong Wu
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

7.  Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARgamma : Possible relevance to human fibrotic disorders.

Authors:  Mónica B Frungieri; Stephan Weidinger; Viktor Meineke; Frank M Köhn; Artur Mayerhofer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-23       Impact factor: 11.205

8.  Nonselective inhibition of prostaglandin-endoperoxide synthases by naproxen ameliorates acute or chronic liver injury in animals.

Authors:  Ralf Bahde; Sorabh Kapoor; Sanjeev Gupta
Journal:  Exp Mol Pathol       Date:  2013-11-10       Impact factor: 3.362

9.  Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis.

Authors:  N A Mohammed; S A Abd El-Aleem; H A El-Hafiz; R F T McMahon; S A El-Aleem
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

10.  Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines.

Authors:  Gao-Song Wu; Sheng-Quan Zou; Zheng-Ren Liu; Zhao-Hui Tang; Ju-Hua Wang
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.